The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 06, 2021

Filed:

Aug. 21, 2014
Applicant:

Verrica Pharmaceuticals Inc., West Chester, PA (US);

Inventor:

Matthew Gene Davidson, Venice, CA (US);

Assignee:

Verrica Pharmaceuticals Inc., West Chester, PA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61J 1/06 (2006.01); A61K 31/34 (2006.01); A61M 35/00 (2006.01); A61J 1/14 (2006.01); A61K 31/343 (2006.01); A61K 9/00 (2006.01); A61J 7/00 (2006.01); A61J 1/20 (2006.01);
U.S. Cl.
CPC ...
A61K 31/34 (2013.01); A61J 1/06 (2013.01); A61J 1/1418 (2015.05); A61K 9/0014 (2013.01); A61K 31/343 (2013.01); A61M 35/003 (2013.01); A61J 1/065 (2013.01); A61J 1/201 (2015.05); A61J 7/0053 (2013.01);
Abstract

Devices, systems, methods, and kits for treating cutaneous diseases, such as warts, with a cantharidin formulation are generally described. The cantharidin formulations, described herein, may have many advantages over traditional cantharidin formulations, including removal of highly volatile and corrosive solvents, improved safety, and improved compatibility with common plastics for ease of delivery. The devices, systems, methods, and kits can be used for the precise application of the cantharidin formulation for the treatment of cutaneous diseases and other topical indications. Treatment of cutaneous diseases with cantharidin, using the devices, systems, methods, and/or kits may have many advantages over traditional therapies, including high single application efficacy, lack of scaring, and a mild pain profile.


Find Patent Forward Citations

Loading…